secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2025-05-02T23:59:59+00:00
Accession:  0001641172-25-008365
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics replaces auditor Marcum with CBIZ after Marcum acquisition
--------------------------------------------------------------------------------

- Marcum resigned as independent auditor on April 30, 2025, following its acquisition by CBIZ.
- Audit Committee approved CBIZ as new auditor for fiscal year ending December 31, 2025.
- Marcum's reports for 2023 and 2024 included a going concern explanatory paragraph; no adverse opinions.
- No disagreements or reportable events between the company and Marcum during the past two fiscal years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000164117225008365/0001641172-25-008365-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000164117225008365/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-008365

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer